ATE243758T1 - Testverfahren und testsatz zur diagnose von autoimmunerkrankungen - Google Patents
Testverfahren und testsatz zur diagnose von autoimmunerkrankungenInfo
- Publication number
- ATE243758T1 ATE243758T1 AT96924655T AT96924655T ATE243758T1 AT E243758 T1 ATE243758 T1 AT E243758T1 AT 96924655 T AT96924655 T AT 96924655T AT 96924655 T AT96924655 T AT 96924655T AT E243758 T1 ATE243758 T1 AT E243758T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- autoimmune diseases
- test
- sec
- diagnosing autoimmune
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 238000010998 test method Methods 0.000 title 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 abstract 1
- 208000017442 Retinal disease Diseases 0.000 abstract 1
- 206010038923 Retinopathy Diseases 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US137095P | 1995-07-21 | 1995-07-21 | |
| PCT/US1996/012026 WO1997004125A1 (en) | 1995-07-21 | 1996-07-19 | Assay methods and kits for diagnosing autoimmune disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE243758T1 true ATE243758T1 (de) | 2003-07-15 |
Family
ID=21695702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96924655T ATE243758T1 (de) | 1995-07-21 | 1996-07-19 | Testverfahren und testsatz zur diagnose von autoimmunerkrankungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6130049A (de) |
| EP (1) | EP0856065B1 (de) |
| AT (1) | ATE243758T1 (de) |
| CA (1) | CA2224666C (de) |
| DE (1) | DE69628847T2 (de) |
| ES (1) | ES2202456T3 (de) |
| WO (1) | WO1997004125A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6165799A (en) * | 1996-12-10 | 2000-12-26 | Heska Corporation | Detection of anti-Fc.sub.ε R autoantibodies in asthmatics |
| IT1320393B1 (it) * | 2000-06-05 | 2003-11-26 | Cselt Centro Studi Lab Telecom | Procedimento per il modellamento elettromagnetico di componenti esistemi elettronici. |
| US7776524B2 (en) | 2002-02-15 | 2010-08-17 | Genzyme Corporation | Methods for analysis of molecular events |
| DE112005001901T5 (de) * | 2004-08-04 | 2007-07-12 | Aspira Biosystems Inc., Incline Village | Einfangen und entfernen von Biomolekülen aus Körperflüssigkeiten unter Verwendung von partiellen molekularen Abdrücken |
| US20060045884A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents | Vaccines for autoimmune and infectious disease |
| US20060045883A1 (en) * | 2004-08-26 | 2006-03-02 | Jeffrey Molldrem | Anti-cancer vaccines |
| WO2006026654A2 (en) | 2004-08-27 | 2006-03-09 | Exact Sciences Corporation | Method for detecting a recombinant event |
| US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
| US20060141547A1 (en) * | 2004-11-16 | 2006-06-29 | Das Hasi R | Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
| US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
| US20120220875A1 (en) * | 2010-04-20 | 2012-08-30 | Suri Jasjit S | Mobile Architecture Using Cloud for Hashimoto's Thyroiditis Disease Classification |
| US20130030281A1 (en) * | 2010-04-20 | 2013-01-31 | Jasjit S Suri | Hashimotos Thyroiditis Detection and Monitoring |
-
1996
- 1996-07-19 DE DE69628847T patent/DE69628847T2/de not_active Expired - Fee Related
- 1996-07-19 AT AT96924655T patent/ATE243758T1/de not_active IP Right Cessation
- 1996-07-19 EP EP96924655A patent/EP0856065B1/de not_active Expired - Lifetime
- 1996-07-19 ES ES96924655T patent/ES2202456T3/es not_active Expired - Lifetime
- 1996-07-19 WO PCT/US1996/012026 patent/WO1997004125A1/en not_active Ceased
- 1996-07-19 CA CA002224666A patent/CA2224666C/en not_active Expired - Fee Related
- 1996-07-19 US US08/983,485 patent/US6130049A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0856065A1 (de) | 1998-08-05 |
| WO1997004125A1 (en) | 1997-02-06 |
| CA2224666A1 (en) | 1997-02-06 |
| EP0856065A4 (de) | 2000-05-31 |
| DE69628847T2 (de) | 2004-05-19 |
| US6130049A (en) | 2000-10-10 |
| EP0856065B1 (de) | 2003-06-25 |
| ES2202456T3 (es) | 2004-04-01 |
| CA2224666C (en) | 2008-11-18 |
| DE69628847D1 (de) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69936523D1 (de) | Assaysystem zur erstbehandlung von darmerkrankungen | |
| ATE243758T1 (de) | Testverfahren und testsatz zur diagnose von autoimmunerkrankungen | |
| AU3538195A (en) | Assays and devices for the detection of extrahepatic biliary atresia | |
| NZ306051A (en) | Testing using electrochemiluminescence | |
| ATE217190T1 (de) | Test und reagentien zur identifizierung von antiproliferierenden stoffen | |
| CY1107621T1 (el) | Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα | |
| ATE76971T1 (de) | Kuevette und apparat zur ausfuehrung biologischer nachweise. | |
| GR3036073T3 (en) | Analytical test apparatus with on board negative and positive control. | |
| ATE366920T1 (de) | Ein-schritt hybridimmunochromatographisches gerät und verfahren zur verwendung | |
| NO331148B1 (no) | Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose. | |
| FI915150A7 (fi) | Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi | |
| DK104093D0 (da) | Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen | |
| DE69719057D1 (de) | Verfahren zur signalverstärkung | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| ATE198512T1 (de) | Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten | |
| PT882229E (pt) | Sistema de ensaio elisa | |
| DE69921987D1 (de) | IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ | |
| ATE192236T1 (de) | Menschliche phospholipase aktivierender proteinteil | |
| DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| WO2003104763A3 (en) | Apparatus and method for relative or quantitative comparison of multiple samples | |
| ATE242487T1 (de) | Verfahren zur bestimmung von schilddrüsen- autoantikörpern | |
| ATE208040T1 (de) | Immunoassay-reagenzien, testsätze und verfahren | |
| DE69912453D1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
| DE69618451D1 (de) | Verfahren zur feststellung einer allergie | |
| IL160531A0 (en) | Compositions and methods for aa4rp assay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |